These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

558 related items for PubMed ID: 24723129

  • 1. Determinants of alpha-fetoprotein levels in patients with hepatocellular carcinoma: implications for its clinical use.
    Giannini EG, Sammito G, Farinati F, Ciccarese F, Pecorelli A, Rapaccini GL, Di Marco M, Caturelli E, Zoli M, Borzio F, Cabibbo G, Felder M, Gasbarrini A, Sacco R, Foschi FG, Missale G, Morisco F, Svegliati Baroni G, Virdone R, Trevisani F, Italian Liver Cancer (ITA.LI.CA) Group.
    Cancer; 2014 Jul 15; 120(14):2150-7. PubMed ID: 24723129
    [Abstract] [Full Text] [Related]

  • 2. Utility of alpha-fetoprotein (AFP) in the screening of patients with virus-related chronic liver disease: does different viral etiology influence AFP levels in HCC? A study in 350 western patients.
    Cedrone A, Covino M, Caturelli E, Pompili M, Lorenzelli G, Villani MR, Valle D, Sperandeo M, Rapaccini GL, Gasbarrini G.
    Hepatogastroenterology; 2000 Jul 15; 47(36):1654-8. PubMed ID: 11149026
    [Abstract] [Full Text] [Related]

  • 3. Des-gamma-carboxyprothrombin, alpha-fetoprotein and AFP-L3 in patients with chronic hepatitis, cirrhosis and hepatocellular carcinoma.
    Durazo FA, Blatt LM, Corey WG, Lin JH, Han S, Saab S, Busuttil RW, Tong MJ.
    J Gastroenterol Hepatol; 2008 Oct 15; 23(10):1541-8. PubMed ID: 18422961
    [Abstract] [Full Text] [Related]

  • 4. Elevated serum vitamin B(12) levels in association with tumor markers as the prognostic factors predictive for poor survival in patients with hepatocellular carcinoma.
    Lin CY, Kuo CS, Lu CL, Wu MY, Huang RF.
    Nutr Cancer; 2010 Oct 15; 62(2):190-7. PubMed ID: 20099193
    [Abstract] [Full Text] [Related]

  • 5. High preoparative levels of serum periostin are associated with poor prognosis in patients with hepatocellular carcinoma after hepatectomy.
    Lv Y, Wang W, Jia WD, Sun QK, Huang M, Zhou HC, Xia HH, Liu WB, Chen H, Sun SN, Xu GL.
    Eur J Surg Oncol; 2013 Oct 15; 39(10):1129-35. PubMed ID: 23916473
    [Abstract] [Full Text] [Related]

  • 6. Alpha-fetoprotein has no prognostic role in small hepatocellular carcinoma identified during surveillance in compensated cirrhosis.
    Giannini EG, Marenco S, Borgonovo G, Savarino V, Farinati F, Del Poggio P, Rapaccini GL, Anna Di Nolfo M, Benvegnù L, Zoli M, Borzio F, Caturelli E, Chiaramonte M, Trevisani F, Italian Liver Cancer (ITA.LI.CA) group.
    Hepatology; 2012 Oct 15; 56(4):1371-9. PubMed ID: 22535689
    [Abstract] [Full Text] [Related]

  • 7.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 8.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 9. Association of serum level of growth differentiation factor 15 with liver cirrhosis and hepatocellular carcinoma.
    Liu X, Chi X, Gong Q, Gao L, Niu Y, Chi X, Cheng M, Si Y, Wang M, Zhong J, Niu J, Yang W.
    PLoS One; 2015 Oct 15; 10(5):e0127518. PubMed ID: 25996938
    [Abstract] [Full Text] [Related]

  • 10. Alpha-fetoprotein as a tumor marker in hepatocellular carcinoma: investigations in south Indian subjects with hepatotropic virus and aflatoxin etiologies.
    Murugavel KG, Mathews S, Jayanthi V, Shankar EM, Hari R, Surendran R, Vengatesan A, Raghuram K, Rajasambandam P, Murali A, Srinivas U, Palaniswamy KR, Pugazhendhi T, Thyagarajan SP.
    Int J Infect Dis; 2008 Nov 15; 12(6):e71-6. PubMed ID: 18658001
    [Abstract] [Full Text] [Related]

  • 11. Assessing prognostic significance of preoperative alpha-fetoprotein in hepatitis B-associated hepatocellular carcinoma: normal is not the new normal.
    Blank S, Wang Q, Fiel MI, Luan W, Kim KW, Kadri H, Mandeli J, Hiotis SP.
    Ann Surg Oncol; 2014 Mar 15; 21(3):986-94. PubMed ID: 24232510
    [Abstract] [Full Text] [Related]

  • 12. Prognostic importance of fucosylated alpha-fetoprotein in hepatocellular carcinoma patients with low alpha-fetoprotein.
    Nouso K, Kobayashi Y, Nakamura S, Kobayashi S, Takayama H, Toshimori J, Kuwaki K, Hagihara H, Onishi H, Miyake Y, Ikeda F, Shiraha H, Takaki A, Iwasaki Y, Kobashi H, Yamamoto K.
    J Gastroenterol Hepatol; 2011 Jul 15; 26(7):1195-200. PubMed ID: 21410750
    [Abstract] [Full Text] [Related]

  • 13. Value of α-fetoprotein in association with clinicopathological features of hepatocellular carcinoma.
    Liu C, Xiao GQ, Yan LN, Li B, Jiang L, Wen TF, Wang WT, Xu MQ, Yang JY.
    World J Gastroenterol; 2013 Mar 21; 19(11):1811-9. PubMed ID: 23555170
    [Abstract] [Full Text] [Related]

  • 14. Clinical utility of AFP-L3% measurement in North American patients with HCV-related cirrhosis.
    Sterling RK, Jeffers L, Gordon F, Sherman M, Venook AP, Reddy KR, Satomura S, Schwartz ME.
    Am J Gastroenterol; 2007 Oct 21; 102(10):2196-205. PubMed ID: 17617202
    [Abstract] [Full Text] [Related]

  • 15. Serum DKK1 as a protein biomarker for the diagnosis of hepatocellular carcinoma: a large-scale, multicentre study.
    Shen Q, Fan J, Yang XR, Tan Y, Zhao W, Xu Y, Wang N, Niu Y, Wu Z, Zhou J, Qiu SJ, Shi YH, Yu B, Tang N, Chu W, Wang M, Wu J, Zhang Z, Yang S, Gu J, Wang H, Qin W.
    Lancet Oncol; 2012 Aug 21; 13(8):817-26. PubMed ID: 22738799
    [Abstract] [Full Text] [Related]

  • 16. Highly sensitive lens culinaris agglutinin-reactive α-fetoprotein is useful for early detection of hepatocellular carcinoma in patients with chronic liver disease.
    Oda K, Ido A, Tamai T, Matsushita M, Kumagai K, Mawatari S, Saishoji A, Kure T, Ohno K, Toyokura E, Imanaka D, Moriuchi A, Uto H, Oketani M, Hashiguchi T, Tsubouchi H.
    Oncol Rep; 2011 Nov 21; 26(5):1227-33. PubMed ID: 21874252
    [Abstract] [Full Text] [Related]

  • 17. A new laboratory-based algorithm to predict development of hepatocellular carcinoma in patients with hepatitis C and cirrhosis.
    El-Serag HB, Kanwal F, Davila JA, Kramer J, Richardson P.
    Gastroenterology; 2014 May 21; 146(5):1249-55.e1. PubMed ID: 24462733
    [Abstract] [Full Text] [Related]

  • 18. Higher Ratio of Serum Alpha-Fetoprotein Could Predict Outcomes in Patients with Hepatitis B Virus-Associated Hepatocellular Carcinoma and Normal Alanine Aminotransferase.
    Kim YI, Kim HS, Park JW.
    PLoS One; 2016 May 21; 11(6):e0157299. PubMed ID: 27304617
    [Abstract] [Full Text] [Related]

  • 19. Evaluation of alpha-fetoprotein staging system for hepatocellular carcinoma in noncirrhotic patients.
    Burnett NP, Dunki-Jacobs EM, Callender GG, Anderson RJ, Scoggins CR, McMasters KM, Martin RC.
    Am Surg; 2013 Jul 21; 79(7):716-22. PubMed ID: 23816006
    [Abstract] [Full Text] [Related]

  • 20. Alpha-L-fucosidase as a serum marker of hepatocellular carcinoma in Thailand.
    Tangkijvanich P, Tosukhowong P, Bunyongyod P, Lertmaharit S, Hanvivatvong O, Kullavanijaya P, Poovorawan Y.
    Southeast Asian J Trop Med Public Health; 1999 Mar 21; 30(1):110-4. PubMed ID: 10695798
    [Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 28.